Disco at The DISC - BTS Discovery Toxicology 2024

BTS Discovery Toxicology 2024:

"Emerging predictive toxicology capabilities across modalities"

Wednesday 12th June 2024

The DISC (AstraZeneca Campus), 1 Francis Crick Avenue, Cambridge, CB2 9FT

Thanks to our sponsors, delegate registration for this meeting is free. To keep the evnt moving forward, please also confirm your registration on email prompt, two weeks prior to the event!

Overview

Safety risks are a major cause of attrition in drug discovery and development. A well designed and delivered toxicology package together with prompt and robust problem solving can make the difference between success and failure.

With advances in novel in vitro and in silico methodologies along with the greater understanding of the underlying mechanisms and biomarkers, discovery toxicology has emerged as a fundamental aspect of early stage R&D and is now recognized as a key step to build for success later in drug development.

This meeting will focus on new modalities in drug disocvery, and the strategies being used to support, and are being considered for implementation in early preclinical safety assessment.

Who should attend?

Since 2018, this one day meeting has showcased strategies that are enabling more efficient and robust approaches to achieve success in drug discovery and development.

This meeting will be of interest to colleagues from all aspects of drug discovery and related disciplines. The event is intended as a forum for all; from early stage researchers and industrial scientists right up to executive level managers. We encourage all of our delegates to bring their knowledge and experience to bear on the newest developments in Discovery and Development Toxicology.

Meeting Agenda

Call for Abstracts: Posters & quick-fire talks

Deadline for Abstracts Submission for Poster presentaion only: 12th May

The conference committee has carefully selected the speaker line up for the day but welcome abstracts for poster presentations. There are a limited number of short talks/presentation opportunities available to high quality abstract submissions.

We encourage submissions researchers of all seniority levels from industry and academia. Any submissions from vendors must be application based and have scientific merit.

P lease refer to the BTS Abstract Submission Guidance for guidelines on abstract format.

To submit an abstract please email your abstract with the subject ‘Discovery Tox Abstract’ to: abstracts@discotox.com for consideration. Please indicate if you wish to be considered for a a spotlight talk in addition to a poster presentation.

Early Career Scientist Bursaries

Bursaries available for UK and Europe based early career scientists.

To apply please email an abstract and 250 words on how the meeting will help develop your career with the subject ‘Discovery Tox Bursary’ to: abstracts@discotox.com

Closing date for application: May 12th 2024

Sponsor & Exhibitor Opportunities

There are opportunities to sponsor and/or exhibit at this event. Please get in touch for more information by emailing: Info@discotox.com

Venue, Travel & Accomodation

Find us as the AstraZeneca DISC, CB2 9FT

Food and refreshments will be provided to all delegates throughout the day. Please indicate an specific dietary requirements during registration. You MUST respond to the emial sent to you two weeks prior to the event to secure your booking.

There is no parking availble at the AZ DISC, please use the Trumpington park and Ride

Please note, there is no affiliated accommodation options for the event. Please make your own arrangements.

Conference Organising Committee

A BTS event organised by its members, open to all!

Carolin Schramm (Nonclinical Safeyty Expert, Sanofi)

Muireann Coen (Senior Director of Oncology Safety, AstraZeneca)

Melanie Z Sakatis (Nonclinical Hepatotoxicity Lead, GSK)

Nicholas Coltman (Deputy Head of Safety Science, ApconiX)

Ruth Roberts (Director, Apconix and Chair of Drug Disocvery, University of Birmingham)